From Université de Lille (S.M., B.C., G.K., C.R., H.H., D.L., C.C.), Inserm U1171, Degenerative and Vascular Cognitive Disorders, CHU Lille; and Departments of Neurology (S.M., B.C., C.R., H.H., D.L., C.C.), Neuroradiology (G.K.), and Neuroradiology (G.B.), Centre Hospitalier Saint-Anne, Université Paris-Descartes, Inserm U894, France.
Neurology. 2018 Jul 10;91(2):e132-e138. doi: 10.1212/WNL.0000000000005778. Epub 2018 Jun 8.
To determine the prevalence of cortical superficial siderosis (cSS), its clinical and neuroimaging associated markers, and its influence on the risk of recurrent intracerebral hemorrhage (ICH) in a prospective observational ICH cohort.
We investigated clinical and radiologic markers associated with cSS using multivariable analysis. In survival analyses, we used Cox models to identify predictors of recurrent ICH after adjusting for potential confounders.
Of the 258 patients included in the study, 49 (19%; 95% confidence interval [CI] 14%-24%) had cSS at baseline. Clinical factors independently associated with the presence of cSS were increasing age (odds ratio [OR] 1.03 per 1-year increase, 95% CI 1.001-1.06, = 0.044), preexisting dementia (OR 2.62, 95% CI 1.05-6.51, = 0.039), and history of ICH (OR 4.02, 95% CI 1.24-12.95, = 0.02). Among radiologic biomarkers, factors independently associated with the presence of cSS were ICH lobar location (OR 24.841, 95% CI 3.2-14.47, < 0.001), severe white matter hyperintensities score (OR 5.51, 95% CI 1.17-5.78, = 0.019), and absence of lacune (OR 4.46, 95% CI 1.06-5.22, = 0.035). During a median follow-up of 6.4 (interquartile range 2.9-8.4) years, recurrent ICH occurred in 19 patients. Only disseminated cSS (hazard ratio 4.69, 95% CI 1.49-14.71, = 0.008), not the presence or absence of cSS or focal cSS on baseline MRI, was associated with recurrent symptomatic ICH.
In a prospective observational cohort of spontaneous ICH, clinical and radiologic markers associated with cSS suggest the implication of underlying cerebral amyloid angiopathy. Disseminated cSS may become a key prognostic neuroimaging marker of recurrent ICH that could be monitored in future clinical trials dedicated to patients with ICH.
在一项前瞻性观察性脑出血队列中,确定皮质浅表铁沉积(cSS)的患病率,其临床和神经影像学相关标志物,以及其对复发性脑出血(ICH)风险的影响。
我们使用多变量分析研究了与 cSS 相关的临床和影像学标志物。在生存分析中,我们使用 Cox 模型在调整潜在混杂因素后,确定复发性 ICH 的预测因素。
在研究的 258 名患者中,49 名(19%;95%置信区间[CI] 14%-24%)在基线时有 cSS。与 cSS 存在独立相关的临床因素包括年龄增加(每增加 1 岁,优势比[OR]为 1.03,95%CI 为 1.001-1.06, = 0.044)、预先存在的痴呆(OR 2.62,95%CI 为 1.05-6.51, = 0.039)和 ICH 病史(OR 4.02,95%CI 为 1.24-12.95, = 0.02)。在影像学生物标志物中,与 cSS 存在独立相关的因素包括 ICH 叶位(OR 24.841,95%CI 为 3.2-14.47,<0.001)、严重的白质高信号评分(OR 5.51,95%CI 为 1.17-5.78, = 0.019)和无腔隙(OR 4.46,95%CI 为 1.06-5.22, = 0.035)。在中位随访 6.4 年(四分位间距 2.9-8.4)期间,19 名患者发生复发性 ICH。只有弥散性 cSS(危险比 4.69,95%CI 为 1.49-14.71, = 0.008),而不是基线 MRI 上 cSS 的存在或不存在或局灶性 cSS,与复发性症状性 ICH 相关。
在一项自发性脑出血的前瞻性观察队列中,与 cSS 相关的临床和影像学标志物提示潜在的脑淀粉样血管病的影响。弥散性 cSS 可能成为复发性 ICH 的关键预后神经影像学标志物,可在未来专门针对 ICH 患者的临床试验中进行监测。